Companies: 10,795·Total market cap: $144.5T
Aoxing Pharmaceutical Company, Inc.

Aoxing Pharmaceutical Company, Inc.

AOXGOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$320107
P/E Ratio—
52W High$0.0107
52W Low$0.0016
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Aoxing Pharmaceutical Company, Inc. (AOXG) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001060426 · AOXG · OTC · as of Jun 9, 2026

Filing snapshot

352
Total Filings
15-12G
Latest Form
2017-10-17
Most Recent
2005
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001060426 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2016-10-05
Fiscal Year End
Oct 5, 2016
Accession No.
0001096906-16-001934
Primary Document
aoxing.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001060426 · Accession 0001096906-16-001934

Latest Key Filings

6-KQuarterly Report

No recent filings

8-KCurrent Report
8K
2017-09-25Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
15-12G15-12G
15-12G
2017-10-17
View
2525
25
2017-10-06
View
EFFECTEFFECT
EFFECT
2017-10-05
View
AWAW
AW
2017-09-29
View
NT 10-KNT 10-K
12B25
2017-09-28
View
POS AMPOS AM
POS AM
2017-09-27
View
S-3/AS-3/A
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3
2017-09-26
View
8-KCurrent Report
8K
2017-09-25
View
8-KCurrent Report
8K
2017-08-04
View
8-KCurrent Report
8K
2017-06-22
View
10-QQuarterly Report
10Q
2017-05-15
View
DEFA14AProxy Statement (Additional)
PRIMARY DOCUMENT
2017-05-11
View
DEF 14AProxy Statement
DEF 14A
2017-05-11
View
10-Q/AQuarterly Report (Amended)
10-Q AMENDMENT NO. 1
2017-02-17
View
10-QQuarterly Report
10Q
2017-02-14
View
Showing 1–15 of 311 filingsForm 4 / 144 hidden· 352 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001060426  |  Exchange: OTC · Healthcare

Aoxing Pharmaceutical Company, Inc. (OTC: AOXG) has submitted 352 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2005. As a Healthcare sector company with CIK 0001060426, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Aoxing Pharmaceutical Company, Inc.'s most comprehensive regulatory disclosure. The most recent Aoxing Pharmaceutical Company, Inc. 10-K was filed on 2016-10-05 for fiscal year ending 2016. Historical AOXG 10-K annual reports are available from 1998 through 2016.

Investors researching Aoxing Pharmaceutical Company, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
VDRM SEC Filings →HMPQ SEC Filings →SFLM SEC Filings →NBIO SEC Filings →RLBD SEC Filings →PZOO SEC Filings →AREVF SEC Filings →FFNTF SEC Filings →
→ AOXG Financials→ AOXG Earnings→ AOXG Insider Trades

Frequently Asked Questions

AOXG SEC Filings · 8 questions

Aoxing Pharmaceutical Company, Inc. (AOXG) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 352 filings and access original documents at no cost. Aoxing Pharmaceutical Company, Inc.'s CIK is 0001060426.

AOXG SEC filingsAoxing Pharmaceutical Company, Inc. SEC documentsfind AOXG 10-K